Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

(Nasdaq: OPTH) (CSE: OPTI) (“Optimi” or the “Company”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today.